| BCBS Premera WA AK Clinical | 5.01.613 Oral Iron Chelating Agents | 2025-02-24 |
| BCBS Premera WA AK Clinical | Chimeric Antigen Receptor Therapy for Multiple Myeloma | 2025-02-24 |
| BCBS Premera WA AK Clinical | Pharmacologic Treatment of Postpartum Depression | 2025-02-24 |
| BCBS Premera WA AK Clinical | 5.01.611 Pharmacologic Treatment of Urea Cycle Disorders | 2025-02-24 |
| BCBS Premera WA AK Clinical | Pharmacologic Treatment of Bladder Cancer | 2025-02-24 |
| BCBS Premera WA AK Clinical | 5.01.607 Continuity of Coverage for Maintenance Medications | 2025-02-24 |
| BCBS Premera WA AK Clinical | 5.01.546 Medical Necessity Criteria for Compounded Medications | 2025-02-24 |
| BCBS Premera WA AK Clinical | Hetlioz (tasimelteon) | 2025-02-24 |
| BCBS Premera WA AK Clinical | Pharmacologic Treatment of Cystinosis | 2025-02-24 |
| BCBS Premera WA AK Clinical | Oral Iron Chelating Agents | 2025-02-24 |